Skip to main content
U.S. Department of Energy
Office of Scientific and Technical Information

PREFERENTIAL INHIBITION OF THE GROWTH OF VIRUS-TRANSFORMED CELLS IN CULTURE BY RIFAZONE-82, A NEW RIFAMYCIN DERIVATIVE

Journal Article · · Proceedings of the National Academy of Sciences
Rifazone-8{sub 2} (R-8{sub 2}), a new rifamycin derivative, is shown to preferentially inhibit the growth of virus-transformed chick cells in culture. Macromolecular synthesis and glucose uptake of transformed cells are also appreciably decreased in the presence of low concentrations of R-8{sub 2} where the normal cells appear unaffected. While R-8{sub 2} is shown to be a selective inhibitor of RNA-directed DNA polymerase in vitro, its action on the growth of transformed cells may involve some other mechanism.
Research Organization:
Ernest Orlando Lawrence Berkeley National Laboratory, Berkeley, CA (US)
Sponsoring Organization:
Life Sciences Division
DOE Contract Number:
AC02-05CH11231
OSTI ID:
939470
Report Number(s):
LBL-2685
Journal Information:
Proceedings of the National Academy of Sciences, Journal Name: Proceedings of the National Academy of Sciences
Country of Publication:
United States
Language:
English

Similar Records

Preferential inhibition of the growth of virus-transformed cells in culture by rifazone-8/sub 2/, a new rifamycin derivative
Journal Article · Fri May 31 20:00:00 EDT 1974 · Proc. Natl. Acad. Sci. U.S.A.; (United States) · OSTI ID:6438290

Inhibition of infectious Rous sarcoma virus production by a rifamycin derivative
Journal Article · Fri Apr 30 20:00:00 EDT 1976 · J. Virol.; (United States) · OSTI ID:7292954

CYTOCIDAL EFFECT OF RIFAMYCIN DERIVATIVES ON ASCITES TUMOR CELLS: STUDIES WITH 125I-IODODEOXYURIDINE
Journal Article · Tue Aug 01 00:00:00 EDT 1978 · Cancer Letters · OSTI ID:1014065